Ensysce Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ensysce Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Ensysce Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 9.89M shares, a 221% increase year-over-year.
  • Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.26M shares, a 1158% increase from 2022.
  • Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 180K shares, a 82.2% decline from 2021.
  • Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.01M shares, a 93.6% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 9.89M +6.8M +221% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 8.82M +6.54M +288% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 5.69M +4.64M +440% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 2.26M +2.08M +1158% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 3.09M +2.93M +1820% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 2.27M +2.13M +1506% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.05M +941K +827% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 180K -828K -82.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 161K -1.05M -86.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 142K -15.9M -99.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 114K -15.7M -99.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 1.01M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 1.21M -14.6M -92.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 16.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 15.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 15.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.